UNIVERSE PHARMACEUTICALS INC (UPC) Stock Price, Forecast & Analysis
USA - NASDAQ:UPC - KYG9442G1385 - Common Stock
UPC Key Statistics, Chart & Performance
The current stock price of UPC is 4.6 USD. In the past month the price decreased by -2.95%. In the past year, price decreased by -96.96%.
UPC Latest News, Press Relases and Analysis
UPC Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 40.77 | 848.53B | ||
| JNJ | JOHNSON & JOHNSON | 17.94 | 448.58B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.41 | 253.37B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.84 | 239.77B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 12.72 | 218.22B | ||
| MRK | MERCK & CO. INC. | 9.36 | 206.04B | ||
| PFE | PFIZER INC | 7.27 | 140.21B | ||
| SNY | SANOFI-ADR | 11.4 | 121.97B | ||
| GSK | GSK PLC-SPON ADR | 7.65 | 93.22B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.02 | 93.67B | ||
| ZTS | ZOETIS INC | 23.21 | 63.97B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 191.71 | 42.38B |
Related stock screener links
About UPC
Company Profile
Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 225 full-time employees. The company went IPO on 2021-03-23. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The firm mainly conducts its businesses within the Chinese market.
Company Info
UNIVERSE PHARMACEUTICALS INC
265 Jingjiu Avenue, Jinggangshan Econ. And Tech. Dev. Zone
Ji'an JIANGXI CN
Employees: 225
Phone: 867968403309
UNIVERSE PHARMACEUTICALS INC / UPC FAQ
What does UNIVERSE PHARMACEUTICALS INC do?
Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 225 full-time employees. The company went IPO on 2021-03-23. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The firm mainly conducts its businesses within the Chinese market.
What is the stock price of UNIVERSE PHARMACEUTICALS INC today?
The current stock price of UPC is 4.6 USD. The price decreased by -2.54% in the last trading session.
Does UNIVERSE PHARMACEUTICALS INC pay dividends?
UPC does not pay a dividend.
What is the ChartMill rating of UNIVERSE PHARMACEUTICALS INC stock?
UPC has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
On which exchange is UPC stock listed?
UPC stock is listed on the Nasdaq exchange.
What is the Price/Earnings (PE) ratio of UNIVERSE PHARMACEUTICALS INC (UPC)?
The PE ratio for UNIVERSE PHARMACEUTICALS INC (UPC) is 0.02. This is based on the reported non-GAAP earnings per share of 191.57 and the current share price of 4.6 USD.
UPC Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to UPC. When comparing the yearly performance of all stocks, UPC is a bad performer in the overall market: 93.45% of all stocks are doing better.
UPC Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to UPC. While UPC seems to be doing ok healthwise, there are quite some concerns on its profitability.
UPC Financial Highlights
Over the last trailing twelve months UPC reported a non-GAAP Earnings per Share(EPS) of 191.57. The EPS increased by 106.13% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.65% | ||
| ROA | 1.35% | ||
| ROE | 1.97% | ||
| Debt/Equity | 0.04 |